These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10623003)

  • 1. Medicare prescription drug benefit variations.
    Manag Care Interface; 1999 Oct; 12(10):36. PubMed ID: 10623003
    [No Abstract]   [Full Text] [Related]  

  • 2. Managed care outlook. Variance in Medicare pharmacy benefits is wide.
    Manag Care; 1999 Oct; 8(10):66. PubMed ID: 10661956
    [No Abstract]   [Full Text] [Related]  

  • 3. Stats & facts. Medicare and pharmaceutical coverage.
    Manag Care Interface; 1999 Apr; 12(4):68-9. PubMed ID: 10387395
    [No Abstract]   [Full Text] [Related]  

  • 4. The implications of a Medicare prescription drug benefit.
    Manag Care Interface; 2000 May; 13(5):44-5. PubMed ID: 11067393
    [No Abstract]   [Full Text] [Related]  

  • 5. Stats & facts. The increasing dominance of the pharmacy benefits manager.
    Manag Care Interface; 1998 May; 11(5):46-7. PubMed ID: 10181551
    [No Abstract]   [Full Text] [Related]  

  • 6. By the numbers. Satisfied seniors, stalled enrollment.
    Treanor K; Desmarais C
    Healthplan; 1999; 40(6):75-6. PubMed ID: 11067354
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special report: the value of pharmaceuticals. Data watch. Managed care and prescription drugs.
    Bus Health; 1991; [VALUE]():6-7. PubMed ID: 10116288
    [No Abstract]   [Full Text] [Related]  

  • 9. By the numbers. A majority of unsubsidized seniors with prescription drug coverage are enrolled in HMOs.
    Welch WP
    Healthplan; 2000; 41(4):71-2. PubMed ID: 11183914
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program.
    Finkelstein A
    J Health Econ; 2004 Jan; 23(1):1-24. PubMed ID: 15154686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managed care outlook. PBM industry stabilizing amid mergers and spinoffs.
    Manag Care; 1999 May; 8(5):60. PubMed ID: 10538059
    [No Abstract]   [Full Text] [Related]  

  • 12. Managed care outlook. Customization of benefits: will diversity continue?
    Manag Care; 1999 Jan; 8(1):60. PubMed ID: 10346102
    [No Abstract]   [Full Text] [Related]  

  • 13. Employers' reactions to the Clinton prescription drug proposal.
    J Nurs Adm; 2000 Dec; 30(12):567-8. PubMed ID: 11138597
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of PBMs in implementing the Medicare prescription drug benefit.
    Atlas RF
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-504-15. PubMed ID: 15513957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are employers doing about prescription drug coverage for retirees?
    Whitmore H; Gabel J
    Bus Health; 2001 Sep; 19(8):23-8. PubMed ID: 11569312
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population.
    Balkrishnan R; Byerly WG; Camacho FT; Shrestha A; Anderson RT
    Am J Manag Care; 2001 Nov; 7(11):1093-100. PubMed ID: 11725812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
    Briesacher B; Stuart B; Shea D
    Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare prescription drugs: a benefit whose time has come.
    Benjamin GC
    Physician Exec; 1999; 25(4):89-90. PubMed ID: 10557496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.